Germline genetic testing followed by consultation with a genetic counselor is clinically impactful and yields high satisfaction for patients with advanced prostate cancer, according to a study published in the May 1 issue of The Journal of Urology. Kelsey E. Breen, from Memorial Sloan Kettering Cancer Center in New York City, and colleagues examined the feasibility and clinical impact of an alternative hereditary genetic testing model for prostate cancer. Individuals with advanced prostate cancer were provided pretest education and referred for testing of 14 genes associated with hereditary prostate cancer. Participants were contacted by a genetic counselor by phone to obtain family history and discuss results. Patient satisfaction with pretest education and the decision to undergo genetic testing, as well as related changes in clinical management, were assessed. Source: Advances and More licensed by HealthDay

read more